Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)
13 Février 2023 - 11:25PM
Edgar (US Regulatory)
Filed Pursuant to Rule 424(b)(3)
Registration No. 333-269176
PROSPECTUS SUPPLEMENT
(To Prospectus dated February 3, 2023)
PROSPECTUS
CREATD, INC.
11,056,636 Shares of Common Stock
This prospectus supplement
amends and supplements the information in the prospectus, dated February 3, 2023 (the “Prospectus”) relating to the offer
and sale of 11,056,636 shares of our common stock by the Selling Stockholders identified in the Prospectus. This prospectus supplement
should be read in conjunction with the Prospectus, and is qualified by reference thereto, except to the extent that the information herein
amends or supersedes the information contained in the Prospectus. This prospectus supplement is not complete without, and may only be
delivered or utilized in connection with, the Prospectus and any future amendments or supplements thereto.
We are filing this prospectus
supplement to amend the Prospectus because, pursuant to that certain letter agreement dated February 10, 2023 (the “Letter Agreement”),
between Creatd, Inc. (the “Company”) and the respective holders of an aggregate of 1,624,415 warrants described in the Prospectus
(the “Warrants”), who are named as Selling Stockholders in the Prospectus, the Company has agreed to amend the exercise price
of the Warrants to $0.20, in exchange for the immediate exercise of the Warrants. In addition, pursuant to the Letter Agreement, the Company
will issue to the Selling Stockholders party thereto, for each Warrant held by such Selling Stockholder, one new warrant to purchase one
share of the Company’s common stock, issued as of February 10, 2023, exercisable immediately, for a term of 60 months, at a price
of $0.77, subject to customary adjustment provisions.
Investing in our securities
involves significant risks. Please see “Risk Factors” beginning on page 5 of the Prospectus and in the documents incorporated
by reference into the Prospectus and in our most recent Annual Report on Form 10-K and in our most recent Quarterly Reports on Form 10-Q,
and any amendments thereto, which are incorporated by reference into the Prospectus, and under similar headings in the other documents
that are filed after the date hereof and incorporated by reference into this prospectus supplement and the Prospectus for a discussion
of the factors you should carefully consider before deciding to purchase our common stock.
Neither the Securities
and Exchange Commission nor any state securities commission has approved or disapproved of these securities or passed upon the adequacy
or accuracy of the Prospectus or this prospectus supplement. Any representation to the contrary is a criminal offense.
The date of this prospectus supplement is February
10, 2023
Creatd (PK) (USOTC:CRTD)
Graphique Historique de l'Action
De Nov 2024 à Déc 2024
Creatd (PK) (USOTC:CRTD)
Graphique Historique de l'Action
De Déc 2023 à Déc 2024